Results 161 to 170 of about 50,945 (202)

Influenza PA Substitutions and Genetic Diversity of A(H1N1)pdm09, A(H3N2), and B/Victoria Viruses in Japan During the 2023-2024 Season. [PDF]

Viruses
Lee N, Tang JW, Chon I, Kakuya F, Terao R, Kawashima T, Sato I, Kodo N, Suzuki E, Masaki H, Asoh N, Shirahige Y, Hamabata H, Tamura T, Wagatsuma K, Sun Y, Li J, Purnama TB, Ichikawa Y, Watanabe H, Saito R.   +20 more
europepmc   +1 more source

Retraction note: Moderate protection from vaccination against influenza A(H3N2) subclade K in Beijing, China, September to December 2025 (Euro Surveill. 2026;31(2)).

Euro Surveill
Eurosurveillance editorial team.
europepmc   +1 more source

Emergence of the novel PA-D27G mutation conferring reduced baloxavir susceptibility in influenza A viruses circulating in China, 2018-2025. [PDF]

Emerg Microbes Infect
Sun B, Sun Y, Wang H, Tang X, Tang W, Mi Y, Shen Z, Xue Q, Lu Y, Zhao X, Ai J, Lu J, Zhang W.   +12 more
europepmc   +1 more source

Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026.

MMWR Morb Mortal Wkly Rep
Maloney P, Reeves EL, Wielgosz K, Price AM, Natarajan K, DeSilva MB, Dascomb K, Klein NP, Tartof SY, Irving SA, Grannis SJ, Ong TC, Weber ZA, Schuster JE, Zerr DM, Michaels MG, Boom JA, Halasa NB, Staat MA, Weinberg GA, House SL, Saade EA, Geffel KM, Gaglani M, Wernli KJ, Murugan V, Martin ET, Bontrager NAB, Kirby MK, Payne AB, Dawood FS, Tannis A, Moline HL, Zhao SK, Adams K, DeCuir J, Olson SM, Chung JR, Lewis N, Flannery B, Reed C, Garg S, Ellington S, CDC Influenza Vaccine Effectiveness Collaborators, CDC Influenza Vaccine Effectiveness Collaborators.   +44 more
europepmc   +1 more source

Elicitation of Protective Immune Responses Against Influenza Virus Following Intranasal Delivery of Fluzone or Flublok Vaccines. [PDF]

Vaccines (Basel)
Uno N, Thomas MH, Caetano C, Ross TM.
europepmc   +1 more source

Estimating influenza A subtype ratios among critical care admissions in England. [PDF]

Epidemiol Infect
Wolmuth-Gordon HS, Elgohari S, Dabrera G, Green RE.   +3 more
europepmc   +1 more source

Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026. [PDF]

Euro Surveill
Lucaccioni H, Marques DF, Kirsebom F, Emborg HD, Hamilton M, Whitaker H, Bolt Botnen A, Bucholc M, Pozo F, Andrews N, Trebbien R, Hameed SS, Lauenborg Møller K, O'Doherty MG, Lopez-Bernal J, Morrison K, Cottrell S, Wilton S, Rose AM, Kissling E, European IVE group.   +20 more
europepmc   +1 more source

Links between influenza epidemics, weather characteristics and all-cause mortality in the Czech Republic, 1982-2020. [PDF]

BMC Public Health
Hanzlíková H, Plavcová E, Kyselý J, Kynčl J, Malý M, Urban A.   +5 more
europepmc   +1 more source

Moderate protection from vaccination against influenza A(H3N2) subclade K in Beijing, China, September to December 2025.

Euro Surveill
Shen Y, Zhang D, Feng Z, Ma C, Shi W, Duan W, Li J, Zhang L, Wu D, Zhang J, Ma J, Wang Y, Hu X, Yan S, Di Y, Zhao J, Xu H, Wang Q, Yang P.   +18 more
europepmc   +1 more source

Viral lineage and mode of exposure modulate within-host spatial dynamics of influenza A viruses in a guinea pig model. [PDF]

J Virol
Leyson CM, Vargas-Maldonado N, Gaddy M, Raghunathan V, Ferreri LM, Sethi M, Patatanian K, Carnaccini S, Ganti K, VanInsberghe D, Lowen AC.   +10 more
europepmc   +1 more source